DFM Funding Monitor
EU dual-use research funding — who's getting it
Horizon Europe dual-use & security-relevant research grants — EC contribution, coordinator and beneficiaries.
Research grants
2657
Updated
2026-07-03
About the data
Source: CORDIS (official EU open data), Horizon Europe civil R&I — the dual-use / security-relevant subset (Cluster 3 Civil Security, defence-relevant keywords, plus EIC deep-tech and space). EDF military R&D is a separate instrument and is not included. Monetary figures are the EC contribution in EUR as published by the Commission.
Contract-award winners → · Awards → · Open tenders →
| Project | Coordinator | Programme | EC contribution | Benef. | CORDIS |
|---|---|---|---|---|---|
| canceR agnOstic immUnoTherapy predIctioN blood-tEstbroad ROUTINE · 2023-08-01–2025-07-31 |
PAMGENE INTERNATIONAL BV | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Building universal quantum computers with self-correcting cat-qubroad CatQubit · 2022-01-01–2025-12-31 |
ALICE & BOB | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| Real-time multi-spectral imaging for accurate detection of cancebroad rMSI · 2022-10-01–2024-09-30 |
THERICON GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| AlkaBurst2.0 – A game changing bioreactor for sustainable producbroad AlkaBurst2.0 · 2022-11-01–2025-07-31 |
ALKION BIOINNOVATIONS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| EUROZIP: European Zinc-Ion Plantbroad EUROZIP · 2024-01-01–2025-12-31 |
ENERPOLY AB | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Confident®, the digital simulation platform that revolutionizes broad Confident · 2022-11-01–2024-10-31 |
PREDISURGE | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| A Health Technology Assessment of a breakthrough technology in tbroad NonInvasive Cortical Bone Microstructure Analysis · 2023-02-01–2026-05-31 |
POROUS GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| AXILES Bionics: Solaris Projectbroad Solaris Project · 2023-07-01–2026-02-28 |
AXILES BIONICS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Brain Interchange ONE SR—the implantable neuromodulation technolbroad BIC ONE · 2022-11-01–2024-10-31 |
CORTEC GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Quantum Computers for Data Centersbroad QCDC · 2023-04-01–2025-03-31 |
ALPINE QUANTUM TECHNOLOGIES GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Microbiome Abundance Profiling: Precision microbiome profiling fbroad Perseus MAP · 2021-10-01–2023-09-30 |
PERSEUS BIOMICS | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| SWAN: Blitzscaling the early detection of skin cancerbroad SWAN · 2022-07-01–2024-12-31 |
SQUAREMIND | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| Targeting Cancer with ERV Vaccinesbroad CancERVacc · 2022-07-01–2025-10-31 |
INPROTHER APS | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Innovative, minimally invasive device to support the natural movbroad Heart Function Support · 2022-09-01–2027-03-31 |
SYNTACH AB | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Disruptive Communication System based on LiFi technology for Spabroad SATELLIFE · 2021-12-01–2023-11-30 |
OLEDCOMM SAS | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Transcatheter Ventricular Repair Device for treatment of Heart Fbroad V-sling · 2022-05-01–2026-04-30 |
CARDIAC SUCCESS LTD | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Opioid-free Pain relief for Enhanced Recovery After Spine fixatibroad OPERAS · 2023-04-01–2026-03-31 |
SENTRYX BV | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| EDGE MULTI SENSING FOR MEDICAL AND PHARMA APPLICATIONSbroad DETERMINATION · 2022-11-01–2024-10-31 |
EZMEMS LTD. | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| The OVAL study for VB-111 treatment of platinum-resistant ovariabroad OVAL · 2022-04-01–2024-03-31 |
VASCULAR BIOGENICS LTD | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| CO2 based Utility-Scale Long Duration Energy Storagebroad CO2 Battery · 2023-02-01–2025-03-31 |
ENERGY DOME SPA | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| An innovative and versatile Additive Manufacturing Process: Dynabroad Dynamic Molding (DM) · 2023-05-01–2025-10-31 |
3DEUS DYNAMICS SAS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| HyperPV, the first GPU-Powered Physical Verification Framework wbroad hyperPV · 2023-01-02–2025-07-01 |
AMSIMCEL SRL | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| BraiN20®: A paradigm shift in Acute Ischemic Stroke (AIS) patienbroad promise · 2023-05-01–2026-04-30 |
TIME IS BRAIN SL | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Closed-loop deep learning in early-stage drug discovery - cloud broad CelerisTx - Celeris One Platform · 2022-07-01–2024-02-29 |
CELERIS THERAPEUTICS GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Cheaper, better batteries from common, safe and available raw mabroad SodiScale · 2022-06-01–2025-05-31 |
BROADBIT BATTERIES OY | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| Leading the way to energy autonomous edge computingbroad EPEAS · 2023-02-01–2025-07-31 |
E-PEAS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| The InDx CMC Implant. A new treatment for thumb base joint arthrbroad InDx CMC Implant · 2022-11-01–2024-04-30 |
LOCI ORTHOPAEDICS LIMITED | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Technology for 3D fibrous eco materialsbroad FibriTech · 2022-09-01–2024-12-31 |
FIBRITECH SP ZOO | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| Revolutionary therapeutic treatment for stopping progression of broad ReTreatPD · 2023-05-01–2025-04-30 |
HERANTIS PHARMA OYJ | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Direct Selective Laser Trabeculoplasty (DSLT): Accessible glaucobroad EyeAccess · 2022-01-01–2022-12-31 |
BELKIN VISION LTD | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Beta-cell recovery to counter diabetesbroad DiogenX · 2023-10-01–2025-09-30 |
DIOGENX SAS | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| An innovative implantable device and management platform to prevbroad FILBERT · 2023-08-01–2025-07-31 |
PARAGATE MEDICAL LTD | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| MIWA - SMART REUSABLE PACKAGINGbroad MIWA - SMART REUSABLE PACKAGING · 2022-01-01–2024-02-29 |
MIWA TECHNOLOGIES, AS | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| Articular Cartilage Treatment with Injectable hydrogel is Valuabbroad ACTIVE · 2022-10-01–2024-09-30 |
HY2CARE BV | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Accelerating scale up and commercialisation of 100% bacteria frebroad Ovavax2 · 2022-11-01–2024-10-31 |
OVAGEN GROUP LIMITED | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| LCTB-21: A DYRK1A protein kinase inhibitor for treatment of cognbroad DOWN-AUTONOMY · 2022-06-01–2026-06-30 |
PERHA PHARMACEUTICALS SAS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Next Generation Augmented Reality technology to improve car safebroad Vision - Augmented Reality Windshield Display · 2023-02-01–2025-07-31 |
EYELIGHTS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Minimally invasive reliAble Glucose monitoring in Intensive Carebroad MAGIC · 2022-12-01–2025-01-31 |
GLUCOSET AS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| The virtual sound platform of the futurebroad Treble · 2023-01-01–2024-06-30 |
TREBLE TECHNOLOGIES EHF | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Next generation HPC/QC in silico drug discovery platform for de broad ATLAS · 2022-09-01–2024-08-31 |
QUBIT PHARMACEUTICALS | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,500,000 | 1 | CORDIS → |
| On-the-go charging system for heavy electric vehicles in ports abroad Elonroad · 2023-08-01–2025-07-31 |
ELONROAD AB | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| The first non-surgical repair for Pelvic Organ Prolapsebroad apyx · 2023-10-01–2025-09-30 |
ESCALA MEDICAL LTD | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| PAH-ADVANCE: Accelerating the Clinical Path of NTP42, a disease-broad PAH-Advance · 2023-01-01–2023-12-31 |
ATXA THERAPEUTICS LTD | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| The critical shift to single-cell formats in functional analysesbroad Cellularity · 2023-08-01–2025-07-31 |
SAMPLIX ApS | HORIZON-EIC-2023-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Fighting Large-Scale Untreated Infectious Diseases with Innovatibroad FLUIDITY · 2023-01-01–2024-12-31 |
MELETIOS THERAPEUTICS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| SINGULARITY: The first quantum software toolbox for financebroad SINGULARITY · 2022-09-01–2024-12-31 |
MULTIVERSE COMPUTING SL | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 2 | CORDIS → |
| The world’s first needle-free continuous glucose monitor to prevbroad PREVENTDIABETES · 2022-02-01–2024-01-31 |
GLUCOMODICUM OY | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
| Fine Line Dispensing Process to apply Narrow Metal Contacts ontobroad HighLine · 2023-02-01–2025-05-31 |
HIGHLINE TECHNOLOGY GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| Saving patients from severe heart failurebroad FLOWMAKER · 2022-10-01–2025-03-31 |
FINEHEART | HORIZON-EIC-2022-ACCELERATOR-01 | €2,500,000 | 1 | CORDIS → |
| EDV2209 – a Paradigm shift in the treatment of stroke.broad EDVance · 2022-01-01–2024-10-31 |
EDVINCE AKTIEBOLAG | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,500,000 | 1 | CORDIS → |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.